The Effects of Inositol on Glucose Metabolism in Patients With Metabolic Syndrome at Risk of Cardiac Fibrosis

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 23, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

January 31, 2026

Conditions

Metabolic SyndromeCardiac Fibrosis

Interventions

DIETARY_SUPPLEMENT

Inositol and alpha-lactalbumin

The administration of an oral formulation based on inositol and alpha-lactalbumin (two sachets/day for 180 days)

Trial Locations (1)

RECRUITING

UOC Medicina Interna e Nefrologia P.O. AQ, L’Aquila